123 related articles for article (PubMed ID: 14751832)
1. Gene targeting by triple helix-forming oligonucleotides.
Majumdar A; Puri N; McCollum N; Richards S; Cuenoud B; Miller P; Seidman MM
Ann N Y Acad Sci; 2003 Dec; 1002():141-53. PubMed ID: 14751832
[TBL] [Abstract][Full Text] [Related]
2. Importance of clustered 2'-O-(2-aminoethyl) residues for the gene targeting activity of triple helix-forming oligonucleotides.
Puri N; Majumdar A; Cuenoud B; Miller PS; Seidman MM
Biochemistry; 2004 Feb; 43(5):1343-51. PubMed ID: 14756571
[TBL] [Abstract][Full Text] [Related]
3. Targeted cross-linking of the human beta-globin gene in living cells mediated by a triple helix forming oligonucleotide.
Shahid KA; Majumdar A; Alam R; Liu ST; Kuan JY; Sui X; Cuenoud B; Glazer PM; Miller PS; Seidman MM
Biochemistry; 2006 Feb; 45(6):1970-8. PubMed ID: 16460044
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle modulation of gene targeting by a triple helix-forming oligonucleotide.
Majumdar A; Puri N; Cuenoud B; Natt F; Martin P; Khorlin A; Dyatkina N; George AJ; Miller PS; Seidman MM
J Biol Chem; 2003 Mar; 278(13):11072-7. PubMed ID: 12538585
[TBL] [Abstract][Full Text] [Related]
5. Minimum number of 2'-O-(2-aminoethyl) residues required for gene knockout activity by triple helix forming oligonucleotides.
Puri N; Majumdar A; Cuenoud B; Natt F; Martin P; Boyd A; Miller PS; Seidman MM
Biochemistry; 2002 Jun; 41(24):7716-24. PubMed ID: 12056903
[TBL] [Abstract][Full Text] [Related]
6. A triple-helix forming oligonucleotide targeting genomic DNA fails to induce mutation.
Reshat R; Priestley CC; Gooderham NJ
Mutagenesis; 2012 Nov; 27(6):713-9. PubMed ID: 22914677
[TBL] [Abstract][Full Text] [Related]
7. Targeted gene knockout mediated by triple helix forming oligonucleotides.
Majumdar A; Khorlin A; Dyatkina N; Lin FL; Powell J; Liu J; Fei Z; Khripine Y; Watanabe KA; George J; Glazer PM; Seidman MM
Nat Genet; 1998 Oct; 20(2):212-4. PubMed ID: 9771719
[TBL] [Abstract][Full Text] [Related]
8. Targeted gene knockout by 2'-O-aminoethyl modified triplex forming oligonucleotides.
Puri N; Majumdar A; Cuenoud B; Natt F; Martin P; Boyd A; Miller PS; Seidman MM
J Biol Chem; 2001 Aug; 276(31):28991-8. PubMed ID: 11389147
[TBL] [Abstract][Full Text] [Related]
9. High-affinity triple helix formation by synthetic oligonucleotides at a site within a selectable mammalian gene.
Vasquez KM; Wensel TG; Hogan ME; Wilson JH
Biochemistry; 1995 May; 34(21):7243-51. PubMed ID: 7766635
[TBL] [Abstract][Full Text] [Related]
10. Targeted gene knock in and sequence modulation mediated by a psoralen-linked triplex-forming oligonucleotide.
Majumdar A; Muniandy PA; Liu J; Liu JL; Liu ST; Cuenoud B; Seidman MM
J Biol Chem; 2008 Apr; 283(17):11244-52. PubMed ID: 18303025
[TBL] [Abstract][Full Text] [Related]
11. The development of bioactive triple helix-forming oligonucleotides.
Seidman MM; Puri N; Majumdar A; Cuenoud B; Miller PS; Alam R
Ann N Y Acad Sci; 2005 Nov; 1058():119-27. PubMed ID: 16394131
[TBL] [Abstract][Full Text] [Related]
12. Extensive sugar modification improves triple helix forming oligonucleotide activity in vitro but reduces activity in vivo.
Alam MR; Majumdar A; Thazhathveetil AK; Liu ST; Liu JL; Puri N; Cuenoud B; Sasaki S; Miller PS; Seidman MM
Biochemistry; 2007 Sep; 46(35):10222-33. PubMed ID: 17691818
[TBL] [Abstract][Full Text] [Related]
13. Enhancement and inhibition by 2'-O-hydroxyethyl residues of gene targeting mediated by triple helix forming oligonucleotides.
Kundu M; Nagatsugi F; Majumdar A; Miller PS; Seidman MM
Nucleosides Nucleotides Nucleic Acids; 2003 Oct; 22(10):1927-38. PubMed ID: 14609232
[TBL] [Abstract][Full Text] [Related]
14. Targeted genome modification via triple helix formation.
Kalish JM; Glazer PM
Ann N Y Acad Sci; 2005 Nov; 1058():151-61. PubMed ID: 16394134
[TBL] [Abstract][Full Text] [Related]
15. Triplex targeted genomic crosslinks enter separable deletion and base substitution pathways.
Richards S; Liu ST; Majumdar A; Liu JL; Nairn RS; Bernier M; Maher V; Seidman MM
Nucleic Acids Res; 2005; 33(17):5382-93. PubMed ID: 16186129
[TBL] [Abstract][Full Text] [Related]
16. Gene targeting via triple-helix formation.
Casey BP; Glazer PM
Prog Nucleic Acid Res Mol Biol; 2001; 67():163-92. PubMed ID: 11525382
[TBL] [Abstract][Full Text] [Related]
17. Potassium-resistant triple helix formation and improved intracellular gene targeting by oligodeoxyribonucleotides containing 7-deazaxanthine.
Faruqi AF; Krawczyk SH; Matteucci MD; Glazer PM
Nucleic Acids Res; 1997 Feb; 25(3):633-40. PubMed ID: 9016606
[TBL] [Abstract][Full Text] [Related]
18. Improved bioactivity of G-rich triplex-forming oligonucleotides containing modified guanine bases.
Rogers FA; Lloyd JA; Tiwari MK
Artif DNA PNA XNA; 2014; 5(1):e27792. PubMed ID: 25483840
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of transcription by platinated triplex-forming oligonucleotides.
Graham MK; Miller PS
J Biol Inorg Chem; 2012 Dec; 17(8):1197-208. PubMed ID: 22965663
[TBL] [Abstract][Full Text] [Related]
20. Accessibility of nuclear DNA to triplex-forming oligonucleotides: the integrated HIV-1 provirus as a target.
Giovannangeli C; Diviacco S; Labrousse V; Gryaznov S; Charneau P; Helene C
Proc Natl Acad Sci U S A; 1997 Jan; 94(1):79-84. PubMed ID: 8990164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]